| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RxSight, Inc. | Director | Common Stock | 1,385,037 | $66,482,607 | $48.00 | 03 Aug 2021 | Indirect |
| EXAGEN INC. | Director | Stock Option(right to buy) | 9,000 | $32,220 | $3.58 | 17 Jun 2021 | Direct |
| RxSight, Inc. | Director | Series G Preferred Stock | 0 | 03 Aug 2021 | Indirect | ||
| RxSight, Inc. | Director | Series H Preferred Stock | 0 | 03 Aug 2021 | Indirect | ||
| RxSight, Inc. | Director | Warrant (right to buy) | 0 | 03 Aug 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | 03 Aug 2021 | 7 | $0 | 4 | Director | 05 Aug 2021, 19:48 |
| RXST | RxSight, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 10:49 |
| XGN | EXAGEN INC. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 08:39 |